Phthalates in Medications May Increase Risk of Childhood Cancers
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Bone Cancer
Increased Risk of Neurocognitive Difficulties in Survivors of Bone Cancer
Researchers sought to measure the risk of long-term neurocognitive outcomes in survivors of osteosarcoma and Ewing sarcoma.
Most NCCN Radiotherapy Recommendations Not Backed by High-Level Evidence
Less than 10% of radiotherapy recommendations in 2020 NCCN guidelines were category 1 recommendations.
Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
- Loading...
Loading...
Loading... 
Loading...